A new world-first trial will examine whether oral medicinal cannabis can affect tumour growth in patients with glioma, a common type of brain cancer. As well as supporting the standard treatment for a brain tumour, researchers also hope that medicinal cannabis will have a positive impact on patient’s quality of life. Read the article here.
Australian Natural Therapeutics Group (ANTG) will ship locally cultivated and […]
Two medicinal marijuana companies have fast-tracked plans to build a […]
ANTG APPOINTS JUSTIN SINCLAIR AS CHIEF SCIENTIFIC OFFICER Australian Natural […]
We are focused on research and development, partnering with leading scientists and medical institutions to develop cannabinoid medicines that offer safe and effective therapeutic benefits.LEARN ABOUT ANTG HERE >